Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

CA-4948

SKU: orb1298434

Description

CA-4948 (Emavusertib) is a small molecule inhibitor targeting IRAK4 and FLT3 kinases. It has demonstrated anti-tumor activity in preclinical research, showing efficacy in both in vitro cellular assays and in vivo models of hematological malignancies.

Research Area

Cardiovascular Research, Cell Biology, Immunology & Inflammation, Signal Transduction

Images & Validation

−

Key Properties

−
CAS Number1801344-14-8
MW491.5
Purity99.88% (May vary between batches)
FormulaC24H25N7O5
SMILESCc1cc(ccn1)-c1nc(co1)C(=O)Nc1cc2oc(nc2nc1N1CC[C@@H](O)C1)N1CCOCC1
TargetIRAK,FLT,MyD88,Apoptosis,NF-κB
Solubility10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (4.07 mM);H2O:< 0.1 mg/mL (insoluble);DMSO:27.78 mg/mL (56.52 mM)

Bioactivity

−
In Vitro
CA-4948, demonstrated good cellular activity in ABC DLBCL and AML cell lines. Inhibition of TLR signaling leading to decreased IL-6 levels was also observed in whole blood assays. CA-4948 demonstrated moderate to high selectivity in a panel of 329 kinases as well as exhibited desirable ADME and PK profiles including good oral bioavailability in mice, rat, and dog and showed >90% tumor growth inhibition in relevant tumor models with excellent correlation with in vivo PD modulation. CA-4948 was well tolerated in toxicity studies in both mouse and dog at efficacious exposure. The overall profile of CA-4948 prompted us to select it as a clinical candidate for evaluation in patients with relapsed or refractory hematologic malignancies including non-Hodgkin lymphoma and acute myeloid leukemia.

Storage & Handling

−
Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

−
Cluster of differentiation antigen 135, CD135, CA 4948, CA-4948, CA4948, arthritis, Inhibitor, FLT3, Fms like tyrosine kinase 3, Emavusertib, Myd88, inhibit, IL-1R, IL-1R associated kinase, Interleukin-1 receptor associated kinase, IRAK, IRAK4, inflammation, lymphoma, rheumatoid, Toll

Similar Products

−
  • IRAK4-IN-7 [orb1301860]

    99.60% (May vary between batches)

    1801343-74-7

    417.42

    C21H19N7O3

    2 mg, 5 mg, 10 mg, 25 mg, 100 mg, 1 mg, 1 ml x 10 mM (in DMSO), 50 mg
  • Emavusertib Maleate [orb2815454]

    2376399-39-0

    607.57

    C28H29N7O9

    50 mg, 100 mg, 25 mg
  • Emavusertib Mesylate [orb2814948]

    2376399-40-3

    587.61

    C25H29N7O8S

    50 mg, 25 mg, 100 mg
  • Emavusertib Tosylate [orb2814951]

    2376399-41-4

    663.7

    C31H33N7O8S

    50 mg, 100 mg, 25 mg
  • Emavusertib Phosphate [orb2814883]

    2376399-38-9

    589.49

    C24H28N7O9P

    100 mg, 25 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

−
No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 70.00
2 mg
$ 90.00
5 mg
$ 110.00
1 ml x 10 mM (in DMSO)
$ 120.00
10 mg
$ 130.00
25 mg
$ 220.00
50 mg
$ 370.00
100 mg
$ 610.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry